The earliest application of NSE in lung diseases was in lung cancer, and it has been widely used and studied in depth, especially in small-cell lung cancer with neuroendocrine functions, where serum NSE levels are significantly elevated [17]. The gene discussed is ENO2; the disease is small cell lung carcinoma.